RecruitingNAINTERVENTIONAL

Establishment of a Prospective Clinical-biological Database

This project is creating a special collection of blood and tissue samples, together with health information, from people in the UK who have sarcoma. Sarcoma is a rare type of cancer that affects bones or soft tissues. The main goal is to build a valuable resource for scientists to better understand sarcoma, how it develops, and why some treatments work better than others. By studying these samples and data, researchers hope to uncover new ways to fight the disease and develop more effective personalised treatments in the future. Participation simply involves providing some leftover tissue from surgery and a blood sample. This database aims to speed up research and ultimately lead to improved care for sarcoma patients.

At a glance

Status

Recruiting

Phase

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle

Enrolment target

450

Start

01 Nov 2016

Estimated completion

01 Nov 2032

Sarcoma

What is this study about?

This study is creating a special database, like a medical library, specifically for people who have been diagnosed with sarcoma. Sarcoma is a rare type of cancer that can develop in various parts of the body, including bones, muscles, fat, and blood vessels. This project is not a clinical trial testing a new drug; instead, it's about collecting valuable information and samples that will help future research.

The database will store two main things: small pieces of tissue that are left over from surgery (like a biopsy or tumour removal) and blood samples. Alongside these, researchers will also collect anonymous health information related to your sarcoma. This combined information will give scientists a much clearer picture of sarcoma at a very detailed level.

By gathering these samples and data, researchers aim to better understand what causes sarcoma to grow, why some types behave differently, and how certain changes in cancer cells affect the disease. This knowledge is crucial for developing new and more effective treatments. While you won't personally receive any new treatment as part of this study, your contribution will be vital in helping future patients and advancing our understanding of sarcoma.

Key takeaways

This study collects blood and leftover tissue samples.
It aims to build a research database for sarcoma.
No new treatments or drugs are given in this study.
Your contribution helps future understanding of sarcoma.
Participation involves minimal effort from you.
Your medical care will not be affected if you join or withdraw.

Who may be eligible?

To take part in this study, you need to be an adult, aged 18 or over. You must have had surgery for sarcoma, whether it's a new diagnosis, a return of the cancer in the same area, or if it has spread to other parts of your body. You should also be willing and able to provide a blood sample, and you might have had radiotherapy treatment before or after your surgery.

Most importantly, you need to be able to understand what the study involves and be happy to sign a consent form, which means you agree to participate.

There are some reasons why you couldn't join. For example, if you are pregnant or breastfeeding, or if you are currently receiving care in an emergency situation. Also, people who are unable to understand the study information due to certain personal circumstances would not be able to participate.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Have you had surgery for sarcoma (new, recurring, or spread)?
Are you able to provide a blood sample?
Are you able to understand the study and agree to take part?
Are you NOT pregnant or breastfeeding?

Answer every question to see your result.

What does participation involve?

If you decide to participate, it will generally involve two main things. Firstly, researchers will ask to use a small leftover piece of tissue from a previous surgery you've had for your sarcoma. This is tissue that would normally be discarded after your diagnosis is made. Secondly, you will be asked to provide a single blood sample. This might be taken at the same time as a routine blood test you're already having, if possible. There are no extra hospital visits required just for this study, and you won't be given any new medications or treatments as part of your involvement. The total duration of your participation simply involves providing these samples at the beginning.

Potential risks and benefits

The potential benefits of taking part in this study are indirect but significant. Your contribution will help researchers gain a better understanding of sarcoma, which could lead to the development of new and improved treatments for future patients. There are very few direct risks. Providing a blood sample carries the usual small risks, such as a brief sting or bruising. Using leftover tissue from surgery means you won't need any additional procedures. You are free to withdraw from the study at any time without giving a reason, and this will not affect your medical care.

Locations (1)

Icm Val D'Aurelle
Verified postcode
Montpellier, France· Recruiting

Common questions

What is the main purpose of this study?

It's building a confidential database of samples and information from sarcoma patients to help researchers learn more about the disease and develop new treatments.

Will I receive any new treatment if I join?

No, this is not a study testing new treatments. It's about collecting information for future research.

What do I need to do if I participate?

You'll provide a blood sample and allow researchers to use a small leftover piece of tissue from your sarcoma surgery.

Will my personal information be kept private?

Yes, all your health information and samples will be handled confidentially and anonymised where appropriate.

Can I change my mind after joining?

Yes, you can withdraw from the study at any time without it affecting your medical care.

How to find out more

Aurore MOUSSION

drci-icm105@icm.unicancer.fr 4 67 61 31 02 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.